Malay Gandhi, Senior VP, Business Operations, Evidation Health
Malay is an active angel investor in early stage, health-focused startups and advises a number of leading health tech companies. Most recently, Malay served as the SVP of Business Operations at Evidation Health, and prior was an EIR at Greylock Partners and led Rock Health as its CEO and Managing Director.
As an investor, Malay originated early stage investments in Benchling, Collective Health, Evidation, Honor, Solv, Stride Health, and Virta amongst others. His research and work in health tech have been cited in the The New York Times, Financial Times, CNBC, NPR, Bloomberg, USA Today, Inc., BuzzFeed, and The Information.
